Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders

Bernard R. Greenberg, Claramae Miller, Robert Cardiff, Malcolm R. Mackenzie, Paula Walling

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.

Original languageEnglish (US)
Pages (from-to)125-133
Number of pages9
JournalBritish Journal of Haematology
Volume53
Issue number1
DOIs
StatePublished - Jan 1 1983

Fingerprint

Plasma Cells
Clone Cells
Lymphocytes
Cellular Structures
B-Lymphocytes
Light
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders. / Greenberg, Bernard R.; Miller, Claramae; Cardiff, Robert; Mackenzie, Malcolm R.; Walling, Paula.

In: British Journal of Haematology, Vol. 53, No. 1, 01.01.1983, p. 125-133.

Research output: Contribution to journalArticle

Greenberg, Bernard R. ; Miller, Claramae ; Cardiff, Robert ; Mackenzie, Malcolm R. ; Walling, Paula. / Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders. In: British Journal of Haematology. 1983 ; Vol. 53, No. 1. pp. 125-133.
@article{866c969f8d2249dc9495a536173af4a6,
title = "Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders",
abstract = "Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.",
author = "Greenberg, {Bernard R.} and Claramae Miller and Robert Cardiff and Mackenzie, {Malcolm R.} and Paula Walling",
year = "1983",
month = "1",
day = "1",
doi = "10.1111/j.1365-2141.1983.tb01994.x",
language = "English (US)",
volume = "53",
pages = "125--133",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders

AU - Greenberg, Bernard R.

AU - Miller, Claramae

AU - Cardiff, Robert

AU - Mackenzie, Malcolm R.

AU - Walling, Paula

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.

AB - Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.

UR - http://www.scopus.com/inward/record.url?scp=0020665192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020665192&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.1983.tb01994.x

DO - 10.1111/j.1365-2141.1983.tb01994.x

M3 - Article

C2 - 6216909

AN - SCOPUS:0020665192

VL - 53

SP - 125

EP - 133

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -